ADAGNasdaq

Adagene Inc.

Alert me on ADAG

Insider buys, 6 months

Congress trades, 6 months

Signals, 6 months

Six months

After each filing

Sep 26 Buy Tam Man Kin Insider

1 week

−12.5%S&P +1.2%

1 month

−19.4%S&P +0.5%

3 months

Result in38 trading days

6 months

Result in101 trading days

Sep 17 Buy Luo Peter Insider

1 week

−11.6%S&P +0.9%

1 month

−38.9%S&P +0.3%

3 months

Result in31 trading days

6 months

Result in94 trading days

Aug 19 Buy DO CUONG V Insider

1 week

−6.6%S&P −0.4%

1 month

−19.7%S&P −0.7%

3 months

Result in11 trading days

6 months

Result in74 trading days

Aug 7 Buy Luo Peter Insider

1 week

−10.0%S&P +0.4%

1 month

−15.1%S&P −0.9%

3 months

Result in3 trading days

6 months

Result in66 trading days

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for ADAG

20 held · newest 520 held · newest 2

Loading the filings.

See all 20 filings for ADAG

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Signal history

Sep 25 Insider

2 insiders bought $70K between them within 9 days

A week later−12.5%S&P +1.2%

A month later−19.4%S&P +0.5%

Result in 38 trading days

Result in 101 trading days

Sep 17 Insider

Luo Peter (CEO) bought $64K

A week later−11.6%S&P +0.9%

A month later−38.9%S&P +0.3%

Result in 31 trading days

Result in 94 trading days

Stakes

Jun 30, 2026 Schedule 13G, amended

WuXi PharmaTech Healthcare Fund I L.P.: 3.5%, 2,891,594 shares

Jun 5, 2026 Schedule 13D, amended

HAN 2020 Irrevocable Trust: 11.2%, 9,390,439 shares

Mar 31, 2026 Schedule 13G, amended

WuXi PharmaTech Healthcare Fund I L.P.: 5.9%, 3,485,038 shares

Apr 30, 2026 Schedule 13G

JANUS HENDERSON GROUP PLC: 10.1%, 6,666,666 shares

Mar 16, 2026 Schedule 13G

Chernett Jorey: 5.1%, 2,389,060 shares

Dec 31, 2025 Schedule 13G, amended

General Atlantic Singapore Fund Pte. Ltd.: 0%, 0 shares

Dec 31, 2025 Schedule 13G, amended

Smith Vincent C: 8.7%, 5,095,351 shares

Sep 30, 2025 Schedule 13G, amended

WuXi PharmaTech Healthcare Fund I L.P.: 7%, 4,121,815 shares

Sep 30, 2025 Schedule 13G, amended

Panacea Venture Healthcare Fund II, L.P.: 3.8%, 2,250,000 shares

Schedule 13D is filed within 5 business days of crossing 5 percent by an investor who may seek to influence the company. Schedule 13G is filed by a passive holder, and a large institution has up to 45 days after the quarter end.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

No lobbying reports on file.